Rob Royea

Rob Royea

CEO & Co-Founder

Listed as one of the Top 40 Medical Transformers for 2016 by Medical Marketing and Management Magazine. Led global efforts of both public and private venture technologies, with demonstrated successes from start-up to over $550M. Positioned Cyrcadia to earn the prestigious Edison award in 2016 as the #1 company in Health and Wellness, Wearable and Sensors Category.

Mark Chennells

Mark Chennells

Co-Founder & Director

Specialised in corporate mergers, acquisitions and restructurings in NZ, Australia, USA, UK and China. Brings over 20 years experience advising and investing in China, during which time he has helped to found several companies and has advised a number of Chinese companies on their international acquisitions.

Chris Bailey

Chris Bailey

Co-Founder & Director

Chris’ professional experience includes acting as an Executive with the IP specialist firm, Rouse (www.rouse.com). Chris brings 18 years of experience in advising overseas companies on the management, protection and commercialisation of their IP assets in China and other countries in Asia.

Dr. Shyamali Singhal

Dr. Shyamali Singhal

Chief Medical Officer

M.D. & Ph.D. in Molecular Pharmacology from Albert Einstein College of Medicine. Specializes in surgical oncology for the treatment breast, melanoma, colon, stomach, liver and pancreatic cancer.

Dr. Vinitha Subbhuraam

Dr. Vinitha Subbhuraam

Director - Analytic Core Lab

Ph.D. in Biomedical Engineering at Nanyang Technological University of Singapore. Brings 10+ years of experience in the medical analytics field, in applied predictive algorithms for the detection of cancers in the breast, ovaries, prostate and thyroid.

Tang Ying

Tang Ying

Director - Business Development

Strong background in media and healthcare transactions in China including the formation of Yuxin Media and Cyrcadia Asia.

Dr. Claudia S. Dyckerhoff

Dr. Claudia S. Dyckerhoff

Director

PhD in business administration and an MBA. Formerly a senior partner at McKinsey with over 10 years of experience in the Asian healthcare and health insurance sectors, leading McKinsey’s China Healthcare Sector team and its Asian Health Services and Systems team until stepping down in 2016. Is currently a Director of Roche AG and Clariant AG.

Rob Royea

Rob Royea

CEO & Co-Founder

Listed as one of the Top 40 Medical Transformers for 2016 by Medical Marketing and Management Magazine. Led global efforts of both public and private venture technologies, with demonstrated successes from start-up to over $550M. Positioned Cyrcadia to earn the prestigious Edison award in 2016 as the #1 company in Health and Wellness, Wearable and Sensors Category.

Mark Chennells

Mark Chennells

Co-Founder & Director

Specialised in corporate mergers, acquisitions and restructurings in NZ, Australia, USA, UK and China. Brings over 20 years experience advising and investing in China, during which time he has helped to found several companies and has advised a number of Chinese companies on their international acquisitions.

Chris Bailey

Chris Bailey

Co-Founder & Director

Chris’ professional experience includes acting as an Executive with the IP specialist firm, Rouse (www.rouse.com). Chris brings 18 years of experience in advising overseas companies on the management, protection and commercialisation of their IP assets in China and other countries in Asia.

Dr. Shyamali Singhal

Dr. Shyamali Singhal

Chief Medical Officer

M.D. & Ph.D. in Molecular Pharmacology from Albert Einstein College of Medicine. Specializes in surgical oncology for the treatment breast, melanoma, colon, stomach, liver and pancreatic cancer.

Dr. Vinitha Subbhuraam

Dr. Vinitha Subbhuraam

Director - Analytic Core Lab

Ph.D. in Biomedical Engineering at Nanyang Technological University of Singapore. Brings 10+ years of experience in the medical analytics field, in applied predictive algorithms for the detection of cancers in the breast, ovaries, prostate and thyroid.

Tang Ying

Tang Ying

Director - Business Development

Strong background in media and healthcare transactions in China including the formation of Yuxin Media and Cyrcadia Asia.

Dr. Claudia S. Dyckerhoff

Dr. Claudia S. Dyckerhoff

Director

PhD in business administration and an MBA. Formerly a senior partner at McKinsey with over 10 years of experience in the Asian healthcare and health insurance sectors, leading McKinsey’s China Healthcare Sector team and its Asian Health Services and Systems team until stepping down in 2016. Is currently a Director of Roche AG and Clariant AG.

FIND OUT MORE

Empowering women with early detection